What should you expect during the Connection Study?

Patients will be asked to stay in the Connection Study for 6 months. Patients will take tablets 3 times daily. Two thirds of patients will receive Dimebon, the drug being studied. One third of patients will receive placebo (sugar pill), which does not contain active medicine. Patients taking placebo will be given the opportunity to receive Dimebon at the end of the 6 months.

Patients and their main caregiver will be seen at their study doctor’s office about 8 times. At each visit, the doctor will assess the patient’s safety and how well the treatment is working, as well as interview the caregiver. Patients will receive medical care throughout the duration of the study.